<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="article-commentary" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Autophagy</journal-id>
<journal-id journal-id-type="iso-abbrev">Autophagy</journal-id>
<journal-id journal-id-type="publisher-id">KAUP</journal-id>
<journal-id journal-id-type="publisher-id">kaup20</journal-id>
<journal-title-group>
<journal-title>Autophagy</journal-title>
</journal-title-group>
<issn pub-type="ppub">1554-8627</issn>
<issn pub-type="epub">1554-8635</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28121223</article-id>
<article-id pub-id-type="pmc">5388227</article-id>
<article-id pub-id-type="publisher-id">1277310</article-id>
<article-id pub-id-type="doi">10.1080/15548627.2016.1277310</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Autophagic Puncta</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Using tuberous sclerosis complex to understand the impact of MTORC1 signaling on mitochondrial dynamics and mitophagy in neurons</article-title>
<alt-title alt-title-type="running-authors">D. EBRAHIMI-FAKHARI ET AL.</alt-title>
<alt-title alt-title-type="running-title">AUTOPHAGY</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="ORCID">0000-0002-0026-4714</contrib-id>
<name>
<surname>Ebrahimi-Fakhari</surname>
<given-names>Darius</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="an0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saffari</surname>
<given-names>Afshin</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wahlster</surname>
<given-names>Lara</given-names>
</name>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="af0003">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahin</surname>
<given-names>Mustafa</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="an0001"></xref>
</contrib>
<aff id="af0001"><label>a</label><institution>The F.M. Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School</institution>, Boston, MA, <country>USA</country></aff>
<aff id="af0002"><label>b</label><institution>Division of Pediatric Neurology and Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg</institution>, Heidelberg, <country>Germany</country></aff>
<aff id="af0003"><label>c</label><institution>Division of Hematology and Oncology, Stem Cell Program, Boston Children's Hospital, Harvard Medical School</institution>, Boston, MA, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="an0001"><bold>CONTACT</bold> Darius Ebrahimi-Fakhari <email xlink:href="darius.ebrahimi-fakhari@childrens.harvard.edu">darius.ebrahimi-fakhari@childrens.harvard.edu</email>; Mustafa Sahin <email xlink:href="mustafa.sahin@childrens.harvard.edu">mustafa.sahin@childrens.harvard.edu</email><institution>Department of Neurology, Boston Children's Hospital</institution>, <addr-line>3 Blackfan Circle, CLS 14073</addr-line>, Boston, MA 02115, <country>USA</country></corresp>
<fn>
<p>Color versions of one or more of the figures in the article can be found online at <ext-link ext-link-type="uri" xlink:href="http://www.tandfonline.com/kaup">www.tandfonline.com/kaup</ext-link>.</p>
</fn>
<fn>
<p>Punctum to: Ebrahimi-Fakhari D, et al. Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex. Cell Rep 2016; 17(4):1053-1070; PMID:27760312; <ext-link ext-link-type="uri" xlink:href="http://http://dx.doi.org/10.1016/j.celrep.2016.09.054">http://dx.doi.org/10.1016/j.celrep.2016.09.054</ext-link></p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>1</month>
<year>2017</year>
</pub-date>
<volume>13</volume>
<issue>4</issue>
<fpage seq="10">754</fpage>
<lpage>756</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 Taylor &amp; Francis</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Taylor &amp; Francis</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="kaup-13-04-1277310.pdf"></self-uri>
<related-article ext-link-type="doi" id="d37e186" related-article-type="commentary-article" xlink:href="10.1016/j.celrep.2016.09.054"></related-article>
<abstract>
<title>ABSTRACT</title>
<p>Constitutive activation of the MTOR pathway is a key feature of defects in the tuberous sclerosis complex and other genetic neurodevelopmental diseases, collectively referred to as MTORopathies. MTORC1 hyperactivity promotes anabolic cell functions such as protein synthesis, yet at the same time catabolic processes such as macroautophagy/autophagy are suppressed. Mitochondria are major substrates of autophagy; however, their role in MTORopathies remains largely undefined. Here, we review our recent study showing that several aspects of mitochondrial function, dynamics and turnover are critically impaired in neuronal models of TSC. We discuss the relevance of these findings to neurological manifestations associated with TSC and speculate on autophagy as a novel treatment target for MTORopathies.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>KEYWORDS</title>
<kwd>autism</kwd>
<kwd>autophagy</kwd>
<kwd>axonal transport</kwd>
<kwd>carbamazepine</kwd>
<kwd>lysosome</kwd>
<kwd>mitochondria</kwd>
<kwd>mTOR</kwd>
<kwd>mTORC1</kwd>
<kwd>rapamycin</kwd>
<kwd>synapse</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="0"></ref-count>
<page-count count="3"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>